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Kajian in silico pulau kepatogenan Salmonella enterica serovar Typhi 
Abstrak 
 
Salmonella enterica serovar Typhi adalah patogen yang spesifik kepada manusia 
yang menyebabkan Demam Kepialu. Adalah dilaporkan bahawa 3-5% pesakit yang 
dijangkiti Demam Kepialu akan menjadi pembawa. Bakteria ini mempunyai beberapa 
pulau genom yang dikenali sebagai pulau kepatogenan Salmonella (SPI). Semua SPI ini 
membawa gen kevirulenan dan gen perlu yang lain dalam jangkitan. Objektif kajian ini 
adalah untuk mengenalpasti semua protein dan interaksi mereka dalam semua pulau 
genomik tersebut. Secara selari, satu kajian perbandingan yang melibatkan kurasi 
manual dan penentuan fungsi secara de novo telah dilakukan ke atas semua genom 
lengkap dan draf strain S. Typhi yang sedia ada. Untuk julung kalinya kajian in silico 
secara terperinci, meluas dan mendalam telah dilakukan untuk mengenalpasti semua 
protein SPI dan pengawalaturan putatifnya. Teknologi pengekstrakan maklumat 
MedScan dan perisian Pathway Studio telah digunakan untuk pembinaan semula laluan 
SPI, manakala analisis BLAST secara meluas telah diaplikasikan untuk menganalisis 
jujukan daripada strain S. Typhi yang lain. Kesimpulannya, koleksi 17 laluan SPI yang 
dibina telah menunjukkan bahawa kesemua SPI adalah saling berinteraksi walaupun 
terletak di lokasi yang berlainan di dalam genom. SPI-1 telah ditunjuk mempunyai 
interaksi dengan bilangan SPI terbanyak kerana ia berhubung dengan SPI-2, 3, 4, 5, 7 
and 18 menerusi sistem PhoP/PhoQ. Beberapa kumpulan gen yang diseekspresi semasa 
serangan makrofag telah dikenalpasti dalam laluan SPI. Berdasarkan kajian 
perbandingan antara genom S. Typhi yang lain, kebanyakan pemain utama di dalam 
SPIs terutamanya faktor transkripsi dan pengawalatur global didapati sememangnya 
xvi 
 
terpelihara dalam seluruh garis keturunan Salmonella. Walaupun genom draf strain S. 
Typhi digunakan dalam kajian perbandingan ini, namun kebanyakannya mempunyai 
gen-gen SPI. Ini menyokong fakta bahawa strain S. Typhi memerlukan SPIs sebagai 
jentera kepatogenannya. Pengetahuan mengenai mekanisme terperinci kevirulenan S. 
Typhi di dalam sel perumah akan membantu dalam perkembangan pengesanan cekap 
serta rawatan untuk Demam Kepialu pada masa hadapan. 
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In silico study of pathogenicity islands of Salmonella enterica serovar Typhi 
Abstract 
 
Salmonella enterica serovar Typhi is a human-specific pathogen that causes 
Typhoid Fever. It is reported that 3-5% of infected patients end up as Typhoid Carriers. 
This bacterium harbors several genomic islands known as Salmonella Pathogenicity 
Islands (SPIs). The SPIs carry virulence and other genes essential for infection. The 
objective of this study is to identify the SPI proteins and their interactions in these 
genomic islands. In parallel, a comparative genomic study for all the SPIs using manual 
curation and de novo functional assignment was performed in all available completed 
and draft genomes of S. Typhi strains.  For the first time, a thorough, extensive and in-
depth in silico study was undertaken to identify all SPI proteins and their putative 
regulation. MedScan information extraction technology and Pathway Studio software 
were the main tools used for the reconstruction of SPI pathways, while extensive 
BLAST analysis were applied to analyze the sequences from other S. Typhi strains. In 
summary, the collection of 17 constructed SPI pathways were shown to be 
interconnected despite their different location on the genome and all of them played an 
important role for Typhoid Fever. It was revealed that SPI-1 is interacting with the 
largest number of SPIs, namely SPI-2, 3, 4, 5, 7, and 18 through the PhoP/PhoQ system. 
Several clusters of genes co-expressed during macrophage invasion were identified in 
the SPI pathways. Based on the comparative studies, it was discovered that most of the 
key players in the SPIs especially the transcription factors and global regulators, were 
indeed conserved throughout the Salmonella lineage. Although draft genomes of S. 
Typhi strains were used in this comparative study, most of them have the SPI genes. 
xviii 
 
This supports the fact that S. Typhi needs SPIs as its pathogenicity machinery. 
Understanding the detailed virulence mechanism of S. Typhi in host cells will help to 
develop efficient detection and treatment of Typhoid Fever in the future.  
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CHAPTER 1 
INTRODUCTION 
The literature review for the research subject is discussed in several sections as shown in 
Figure 1.1.  
 
 
 
 
Figure 1.1: Topics of literature review 
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1.1 Salmonella Typhi and Typhoid Fever 
1.1.1 Salmonella serovars      
 
Salmonella is a genus within the family Enterobacteriacea and thus are under the same 
category of enteric bacteria such as Escherichia coli and Shigella species (Baker and 
Dougan, 2007). The genus Salmonella was named after Daniel Elmer Salmon, an 
American veterinary pathologist. With the advancement in genome sequencing and 
microarray technology, the taxonomy of Salmonella is heavily revised. Sequence 
comparisons revealed that many of the Salmonella are very closely related. This is 
supported by the findings that the sequence identities of house-keeping genes and 16S 
rRNA were between 96% and 99% for the different Salmonella investigated (Porwollik 
and McClelland, 2003). The genus Salmonella contains two main species, namely the 
Salmonella bongori with 20 different serotypes and Salmonella enterica which has 2463 
different serotypes (Table 1.1). S. enterica can be classified into six subspecies: enterica 
(subspecies I), salamae (subspecies II), arizonae (subspecies IIIa), diarizonae 
(subspecies IIIb), houtenae (subspecies IV), and indica (subspecies VI) (Brenner et al., 
2000). This classification is based on the expression of somatic lipopolysaccharide O 
antigens and flagellar H antigens according to the Kaufmann-White serotyping scheme 
(Brenner et al., 2000). From the clinical point of view, the serovars of Salmonella are 
usually divided into two broad groups. The first group consists of human-host restricted 
pathogens and responsible for the systemic invasive disease such as enteric fever. These 
include Salmonella Typhi and Salmonella Paratyphi A, B and C. The other serovars are 
grouped as non-typhoidal Salmonella (NTS), which is usually self-limiting and cause a 
less severe gastroenteritis (Cooke et al., 2007) 
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The most prevalent serovars which cause a major health threat to warm-blooded animals 
are within S. enterica subspecies I while other subspecies and S. bongori are normally 
restricted to cold-blooded hosts (Brenner et al., 2000). Although there is genetic 
relatedness among the S. enterica serovars, they differ significantly in their disease 
spectrum and host range. The best example for broad-host range serovar is S. enterica 
serovar Typhimurium which causes disease in humans, cattle, pigs, horses, poultry, 
rodents and sheep. On the other hand, some serovars are host-specific and have a narrow 
spectrum of hosts. This is best represented by S. enterica serovar Typhi which affects 
mainly humans and higher primates (Porwollik and McClelland, 2003). Most of the S. 
enterica subspecies I serotypes especially the nontyphoidal Salmonella serotypes cause 
infections in humans that are restricted to the intestine and mesenteric lymph node which 
result in diarrhea. In contrast, the typhoidal Salmonella serotypes such as S. Typhi and 
Paratyphi A cause systemic infections in human but diarrhea is an insignificant symptom 
(Santos et al., 2001; Zhang et al., 2003). 
 
Table 1.1: Salmonella species, subspecies, serotypes and their usual habitats 
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Microarray analysis and the complete genome of four S. enterica subspecies I serotypes; 
S. enterica serovar Typhimurium LT2, S. enterica serovar Typhi Ty2, S. enterica 
serovar Typhi CT18, and S. enterica serovar Paratyphi A,  have provided a list of genes 
which are considered as signature genes exclusive for S. enterica subspecies I (Andrews-
Polymenis and Baumler, 2006). The first group of genes encode products that are 
located in the bacterial outer membrane (Porwollik et al., 2002), including the fimbrial 
gene clusters stfACDEFG, safABCD, and stfABCD (Folkesson et al., 1999; Townsend et 
al., 2001). The second group of genes encodes products that affect the properties of the 
bacterial cell surface. This includes the O-antigen biosynthesis (rfb) genes such as rfbP, 
rfbK, rfbU, rfbI, rfbC and rfbM (Porwollik et al., 2002) which are required for host-
pathogen interaction. The third group of genes encodes products that are involved in 
transport and utilization of nutrients such as sugar phosphotransferase and phosphonate 
transport system (Jiang et al., 1995). Figure 1.2 shows the shape of S. Typhi. 
 
 
Figure 1.2: Salmonella enterica serovar Typhi 
Image by Dr. Volker Brinkmann, Max Planck Institute for Infection Biology (Daily, 
2006) Source: http://www.sciencedaily.com/releases/2006/11/061128092129.htm 
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1.1.2 Salmonella enterica serovar Typhi 
S. enterica serovar Typhi is a rod-shaped, gram-negative facultative anaerobe bacterium 
classified under Salmonella subgroup I. It belongs to the family of Enterobacteriaceae. 
All Enterobacteriaceae ferment glucose, reduce nitrates and are oxidative negative. S. 
Typhi is motile, produces minimal H2S and is resistant to bile acids (Rollins and Joseph, 
2000). It has type IV pili, fimbriae for adherence and flagella. Fimbriae or pili are 
defined as structures found on bacteria which mediate interaction with cells. They are 
normally specific to a receptor and thus are used at different critical times during the 
infection. Type IV pili in S. Typhi are used for adhesion to human monocytes and 
epithelial cells by interaction with the cystic fibrosis transmembrane conductance 
regulator receptor (Pier et al., 1998; Tsui et al., 2003; Zhang et al., 2000). Meanwhile, 
Tcf fimbriae was recognized by human sera from typhoid patients (Harris et al., 2006) 
and Stg fimbriae mediates adherence to epithelial cells and reduces phagocytosis (Forest 
et al., 2007). The major subunit of flagella in Salmonella is generally encoded by fliC 
and fliB, which correspond to the H1 and H2 variants of the H antigen, respectively 
(Silverman and Simon, 1980). S. Typhi has 3 types of antigens, namely the H antigen for 
motility, specific O antigen for synthesizing lipopolysaccharides and biofilm formation 
and Vi antigen, a capsular polysaccharide which acts as a major virulence factor of S. 
Typhi.  S. Typhi can be identified in the laboratory by several biochemical and 
serological tests. One of the most specific is that of polysaccharide capsule Vi, which is 
present in about 90% of all freshly isolated S. Typhi and has a protective effect against 
the bactericidal action of the serum of infected patients. This capsule provides the basis 
for one of the commercially available vaccines.  
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1.1.3 Typhoid fever 
Typhoid fever is a global health issue that is caused by S. enterica serovar Typhi (Figure 
1.3).  S. Typhi does not have an animal reservoir and is transmitted from human-to-
human through contaminated food or water (Raffatellu et al., 2007). In developing 
countries, typhoid fever causes 5% or more deaths in areas with high transmission. The 
estimated global incidence of typhoid is 16,000,000 cases with 500,000 deaths per year 
(Pang et al., 1995). Typhoid fever can be classified into multiple stages: progressive 
elevation of temperature, followed by bacteremia; rose spots in the skin, abdominal pain 
and splenomegaly, and finally intensive intestinal inflammatory process especially in the 
Peyer’s patches (de Andrade and de Andrade Junior, 2003).   
 
 
 
Figure 1.3: Distribution of Typhoid Fever worldwide 
Source: Figure released by Centers for Diseases Control and Prevention, (CDC) 
(Review, 2009) (http://vaccinereview.com/who-needs-a-typhoid-vaccination) 
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1.1.4 Pathophysiology-Infection of Salmonella Typhi 
 
The route of S. Typhi infection begins with the ingestion of S. Typhi orally (Figure 1.4 
and Figure 1.5). The bacteria will first enter the small intestine through the M cells of 
Peyer’s patches (PP), the main transmitting point for macrophages traveling from the gut 
into the lymphatic system. S. Typhi has specialized fimbriae that enable it to adhere to 
the epithelium over clusters of lymphoid tissue in the ileum (PP). This is then followed 
by the migration into the mesenteric lymph nodes where multiplication of bacteria 
happens. Multiplication also occurs in lymph nodes, spleen, bone marrow and liver. 
Bacteria are released and disseminated into the bloodstream (Everest et al., 2001). 
During invasion of intestinal epithelial cells, Type Three Secretion System (TTSS) in 
SPI-1 is activated and the effector proteins are injected into the host cell causing the cell 
to form membrane ruffles which will engulf the bacteria and create vesicles. The 
bacteria are then carried in the vesicles across the membrane and presented to the 
macrophages. Macrophages recognize pathogen-associated molecular patterns (PAMPs) 
such as flagella and lipopolysaccharides with the presence of toll-like receptor (TLR)–5 
and TLR-4/MD2/CD-14 complex.  S. Typhi has a Vi capsular antigen that masks 
PAMPs, avoiding neutrophil-based inflammation. TviA avoids interleukin-8 production 
in the intestinal mucosa by repressing flagellin secretion, which reduces the recognition 
and activation of TLR-5 (Raffatellu et al., 2005; Winter et al., 2008). The bacteria then 
induce their host macrophages to attract more macrophages (Raffatellu et al., 2006). S. 
Typhi uses macrophages as a vehicle to specific organs. Since they are undetected by the 
immune system, they are resistant to digestion. Furthermore, S. Typhi has SPI-2 which 
codes for virulence factors that prevent or alter the fusion of the vacuole with other 
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intracellular compartments.  The presence of TTSS in SPI-2 causes pore insertion in the 
vacuole membrane to deliver bacterial effectors. As a result, the macrophage 
cytoskeleton is rearranged to carry S. Typhi in its vacuole to the Golgi apparatus where 
it multiplies. 
 
Figure 1.4: Biology of Salmonella infection – Orally ingested Salmonella survive at the 
low pH of the stomach and evade the multiple defences of the small intestine in order to 
gain access to the epithelium. Source: Adapted from (Haraga et al., 2008) 
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Figure 1.5: Route taken by S. Typhi during infection 
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1.1.5  Typhoid Carrier 
Typhoid fever is mainly transmitted by the ingestion of food or water contaminated with 
feces from the typhoid carrier. A typhoid carrier is normally asymptomatic but this 
individual can carry S. Typhi for days to years without showing any symptom of 
Typhoid fever. The gallbladder is the most common site for the chronic carriage of S. 
Typhi as compared to other site.  It was reported that women exceed men as carriers by a 
ratio of 3:1 (Ames and Robins, 1943; Hornick et al., 1970). Typhoid carrier can be 
divided into three categories according to the Health and Human Services Agency in the 
State of California: 
 Convalesent carrier: 
- A person who harbours S. Typhi for 3 or more months after the onset. 
Convalescent carriers may be released from the hospital when three 
consecutive negative specimens of feces and urine taken at intervals of not 
less than one month, beginning at least one week after discontinuation of 
specific therapy obtained. 
 Acute chronic carrier:  
- A person who carries S. Typhi for more than 6 months and less than one year. 
 Chronic carrier:  
- A person who continues to excrete S. Typhi for more than 12 months after 
the onset of Typhoid fever.  
- Any person who gives no history of having Typhoid fever or who had the 
disease for more than one year previously, whose feces or urine are found to 
contain S. Typhi on 2 separate examinations at least 48 hours apart, 
confirmed by State’s Microbial Diseases Laboratory. 
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On the other hand, it was reported that about 10% of the apparently healthy population 
was found to be chronic typhoid carriers based on Vi serology in endemic areas (Mohan 
et al., 2006). In a recent study, it was reported that in chronic carriers, the liver is the 
major organ where S. Typhi persists and from where it is excreted sporadically into the 
gallbladder. Involvement of the liver during acute typhoid fever can be predicted based 
on the occurrence of hepatomegaly, jaundice, and the increased level of serum enzymes 
and bilirubin. Bile is released at intervals with food ingestion but it is always stored in 
the gallbladder which in turn serves as a reservoir for bacterial multiplication (Nath et 
al., 2010). The chronic carrier state is usually associated with gallbladder abnormalities 
such as gallstones to which Salmonella can adhere (Lai et al., 1992). It was shown that 
biofilm formation is only observed on gallstones when the bile was added to the medium, 
which indicates that bile signals the formation of biofilm. 
 
1.1.6 Biofilm  
Biofilm is composed of different constituents, whereby the biofilm composition and 
regulation depends on environmental conditions.  In general, cells produce and embed 
themselves in a matrix of extracellular polymeric substances which is composed of 
polysaccharides and smaller amounts of protein and DNA (Flemming et al., 2007; 
Nadell et al., 2009). The significant feature in biofilm development of many bacterial 
pathogens is a mucoid-like substance known as exopolysaccharides (EPS) or 
extracellular matrix (Danese et al., 2000). 
To date, the functions of EPS remain unclear but it does promote surface attachment and 
provide structural support. Indeed, it was shown that mutants that cannot produce EPS 
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are often deficient in biofilm formation (Danese et al., 2000; Hammer and Bassler, 2003; 
Nadell et al., 2009). It was proposed that EPS may serve as protection from external 
threats including antimicrobial compounds and predatory organisms or aid secreting 
strains to grow towards nutrient-rich locations. The EPS matrix varies from different 
organism; alginate is formed by Pseudomonas aeruginosa when forming biofilm in 
cystic fibrosis patients (Davies et al., 1993), cellulose in S. enterica serovar Enteritidis 
(Solano et al., 2002) and colanic acid in Esherichia coli (Danese et al., 2000). 
The common components of EPS are colanic acid and cellulose.  Colanic acid is a 
polysaccharide comprised of repeating subunit that is believed to be expressed 
extracellularly when E. coli cells attach to abiotic surfaces (Danese et al., 2000; 
Ledeboer and Jones, 2005). According to Danese et al., (2000), production of colanic 
acid is not essential for initial bacteria attachment but is required for subsequent three 
dimensional biofilm development on abiotic surfaces. The colanic acid biosynthetic gene 
cluster of E. coli has been identified and a similar set of genes is found in S. 
Typhimurium.  
On the other hand, distinct bacterial species belonging to the family of 
Enterobacteriaceae harbor a characteristic cellulose biosynthesis operon (bcs). A 
regulatory network for cellulose biosynthesis has been identified in S. Typhimurium and 
this organism is capable of producing cellulose as an exopolysaccharide (Romling, 
2007). The regulation of colanic acid biosynthesis in Salmonella has not been studied in 
detail. It was proposed that it is likely that EPS production is induced by an unknown 
signal in the developing biofilm environment, where the EPS stabilizes the growing 
biofilm structure. Enzymes leading to EPS formation can be divided into four groups: 
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enzymes responsible for the initial metabolism of a carbohydrate; enzymes involved in 
sugar nucleotide synthesis and interconversion; glycosyltransferase that form the 
repeating unit attached to the glycosyl carrier lipid; and translocases and polymerases 
that form the polymer (Solano et al., 2002).  
1.1.7 Diagnostic kit for Typhoid Fever 
Knowing the fact that Typhoid fever is fatal, it is of much importance to design an 
effective diagnostic kit to detect this disease. Indeed, any secreted or outer membrane 
protein encoded by the SPIs could be used as a biomarker for diagnostic and treatment 
purposes. There are a few diagnostic kits to detect typhoid fever such as the Felix-Widal 
test, IDL Tubex® test, Typhidot®, Typhidot-M®, and IgM dipstick test. Felix-Widal 
test measures agglutinating antibody levels against O and H antigens. Generally, O 
antibodies appear on days 6-8 and H antibodies on days 10-12 after the onset of the 
disease. The test is usually performed on an acute serum (at first contact with the 
patient). It can be negative in up to 30% of culture-proven cases of typhoid fever, due to 
the prior antibiotic therapy that has blunted the antibody response. Thus, the test has 
only moderate sensitivity and specificity. On the other hand, S. Typhi shares O and H 
antigens with other Salmonella serotypes and has cross-reacting epitopes with other 
Enterobacteriacae, and this can lead to a false-positive result. The IDL Tubex® test 
marketed by a Swedish company can detect IgM O9 antibodies from patients within a 
few minutes. The Tubex® test is simple (essentially a one-step test) and rapid (taking 
approximately two minutes). Specificity is improved by means of an inhibition assay 
format and by detecting antibodies to a single antigen in S. Typhi only (WHO, 2003). 
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Another rapid serological test, Typhidot®, takes three hours to perform. It was 
developed in Malaysia for the detection of specific IgM and IgG antibodies against a 50 
kD antigen of S. Typhi (Ismail et al., 1991). This dot EIA test offers simplicity, speed, 
specificity (75%), economy, early diagnosis, sensitivity (95%) and high negative and 
positive predictive values. The detection of IgM reveals acute typhoid in the early phase 
of infection, while the detection of both IgG and IgM suggests acute typhoid in the 
middle phase of infection (WHO, 2003). Since IgG can persist for more than two years 
after typhoid infection (Choo et al., 1999), the detection of specific IgG cannot 
differentiate between acute and convalescent cases. Furthermore, false-positive results 
attributable to previous infection may occur.  A newer version of the test, Typhidot-M®, 
was recently developed to detect specific IgM antibodies only. Evaluation studies have 
shown that Typhidot-M® is superior than the culture method (Choo et al., 1997).  
The dipstick test, developed in the Netherlands, is based on the binding of S. Typhi 
specific IgM antibodies in samples to S. Typhi lipopolysaccharide (LPS) antigen and the 
staining of bound antibodies by an anti-human IgM antibody conjugated to colloidal dye 
particles. Evaluations of the dipstick test in laboratory-based studies in Indonesia (Hatta 
et al., 2002; House et al., 2001), Kenya, Vietnam (Gasem et al., 2002) and Egypt (Ismail 
et al., 2002) have shown consistent results. These studies indicated sensitivities of 65% 
to 77% for samples collected at the time of first consultation from culture-confirmed 
patients and specificities of 95% to 100%. The dipstick test provides a rapid and simple 
alternative for the diagnosis of typhoid fever, particularly in situations where culture 
facilities are not available.  
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Thus, understanding the pathogen and host interaction as well as the genome and 
genetics of the pathogen is essential in order to unravel the underlying mechanism of 
Typhoid fever. 
 
1.2 Genome and Genetics of S. Typhi 
1.2.1 Microbial genome sequencing 
For the past decade, there is a rapid advancement in the DNA sequencing technology. In 
a microbial genome project, whole genome sequencing represents the most powerful 
approach for identification of genomic diversity among closely related strains or 
isolates. A complete genome will provide the information about the presence or absence 
of genes that are crucial to deduce the events in genome evolution such as gene loss, 
gene duplication and lateral gene transfer (Fraser et al., 2002). It was postulated for the 
next few years, more than 100 projects for sequencing microbial genomes should be 
completed, providing the scientific community with information on more than 300,000 
predicted genes with some of them being significant number of novel genes for future 
research and potential biological resources. With more genomes becoming available, the 
benefits of comparative genomics in understanding biochemical diversity, virulence, 
pathogenesis, and the evolution of species has been explicitly demonstrated (Fraser et 
al., 2000).  The number of bacterial genome sequences available has increased 
progressively as reported by the Genomes OnLine Database (Figure 1.6). The Genomes 
OnLine Database (GOLD) is a comprehensive resource for centralized monitoring of 
genome and metagenome projects worldwide. As of September 2009, GOLD contains 
information for more than 5800 sequencing projects of which 1100 have been 
completed.  
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Figure 1.6: Evolution of the complete and ongoing genome projects monitored in 
Genomes OnLine Database (GOLD) from December 1997 through September 2009. 
Source: Adapted from (Liolios et al., 2010).  
 
 
 
1.2.2 Genome of Salmonella Typhi 
 
To date, there are two complete genomes of S. Typhi have been deposited in Genbank. S. 
Typhi CT18 (Figure 1.7) was the first S. Typhi genome sequenced by the Wellcome 
Trust Sanger Institute in 2000, followed by S. Typhi Ty2 (Figure 1.8) which was 
sequenced by the Laboratory of Genetics and Genome Center of Wisconsin in 2002. The 
complete genome of S. Typhi CT18 consists of 4,809,037 base pair with over 200 
pseudogenes, whereby several genes contribute to the virulence in S. Typhimurium. 
Approximately 480 genes are unique to S. Typhimurium and roughly 600 genes are 
unique to S. Typhi (Parkhill et al., 2001). However, it was shown that both serovars 
share about 89% of the genes (McClelland et al., 2001). Similarly, the 4.8 Mb complete 
genome sequence of S. Typhi Ty2 revealed that 4516 genes are shared with S. Typhi 
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CT18, 29 of the 4,646 predicted genes in Ty2 are unique to this strain while 84 genes are 
unique to S. Typhi CT18. 
 
 
 
Figure 1.7: Circular representation of the S. Typhi genome. The outer scale is marked in  
megabases. Circles range from 1 (outer circle) to 9 (inner circle). Circles 1 and 2, genes 
on forward and reverse strand; circles 3 and 4, genes conserved with E. coli; circles 5 
and 6, genes unique to S. Typhi with respect to E. coli; circle 7, pseudogenes; circle 8, 
G+C content; circle 9, GC bias ((G - C/G +C); khaki indicates values .1; purple ,1). All 
genes are colour-coded by function: dark blue, pathogenicity/adaptation; black, energy 
metabolism; red, information transfer; dark green, membranes/surface structures; cyan, 
degradation of macromolecules; purple, degradation of small molecules; yellow, central/ 
intermediary metabolism; light blue, regulators; pink, phage/IS elements; orange, 
conserved hypothetical; pale green, unknown function; brown, pseudogenes. Figure 
reproduced from (Parkhill et al., 2001) 
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Figure 1.8: Circular genome map of Ty2. The Ty2 genome has 4,545 ORFs and 
pseudogenes, 4,516 of which are shared with CT18 (outer circle, blue) and 29 of which 
are unique (pink). Arrowheads within the second circle show the locations and 
orientations of rRNA operons (red) and tRNAs (turquoise) (not drawn to scale). The 
third circle shows insertion element distributions: blue, IS200; red, other IS elements. 
The fourth circle shows the scale in base pairs. The fifth circle shows the C/G skew, 
calculated for each sliding window of 10 kb along the genome. The sixth and seventh 
(innermost) circles show the CT18 and Ty2 genome comparison: blue (and above the 
axis in CT18) indicates colinear regions, red (and below the axis in CT18) indicates 
inverted regions, green indicates a region that is translocated and inverted again within 
the half-genome inversion region, and yellow indicates unique regions. The map was 
created with GenVision (DNASTAR). Figure reproduced from (Deng et al., 2003) 
 
 
 
It was revealed that both strains have significant differences in term of prophages, 
insertion sequences, and island structures (Deng et al., 2003). One of the major 
differences is that S. Typhi Ty2 has no plasmids and is sensitive to antibiotics. In 
contrast, S. Typhi CT18 is multidrug resistant and has 2 plasmids: multiple-drug-
resistance incH1 plasmid, pHCM1 (218,150 bp), and a cryptic plasmid, pHCM2 
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(106,516 bp) (Parkhill et al., 2001). Details for genome S. Typhi CT18 is shown in 
Table 1.2. 
 
Table 1.2: Features of S. Typhi CT18 genome 
 
Component of genome Property 
Chromosome  
Total size 4,809,307 bp 
G+C content 52.09% 
Coding sequences 4,599 
…of which pseudogenes 204 
Coding density 87.6% 
Average gene length 958 bp 
Ribosomal RNAs  6 x (16S-23S-5S), 1 x (16S-23S-5S-5S) 
Transfer RNAs 78 
Other stable RNAs 8 
pHCM1  
Total size 218,150 bp 
G+C content 47.58% 
Coding sequences 249 
…of which pseudogenes 8 
Coding density 83.8% 
Average gene length 759 bp 
pHCM2  
Total size 106,516 bp 
G+C content 50.6% 
Coding sequences 131 
…of which pseudogenes 0 
Coding density 87.1% 
Average gene length 708 bp 
Transfer RNAs 1 
 
 
In 2008, Holt and colleagues have generated whole-genome sequences for 19 Typhi 
isolates (Table 1.3) using 454 (Roche) and Solexa (Illumina) (Holt et al., 2008). It was 
discovered that this human-restricted bacterial pathogen shows limited genetic variation. 
Based on the examination of DNA sequences and the rate of change of single-nucleotide 
polymorphisms, it was proposed that S. Typhi could be only 50,000 years old, and thus it 
is a short time frame for bacteria to accumulate diversity (Kidgell et al., 2002; Sabbagh 
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et al., 2010). This is in consensus with the suggestion that evolution of S. Typhi strain 
population is mainly described by loss of gene function.  Indeed, S. Typhi represents an 
example of reductive evolution, whereby the adaptation to its human niche has caused 
functional inactivation of genes, due to the fact that certain needs have been assured by 
the host (Dagan et al., 2006; Sabbagh et al., 2010). As a result, there are more than 200 
pseudogenes found in both the genome of S. Typhi CT18 and Ty2 (Deng et al., 2003). 
 
Table 1.3: Typhi isolates sequenced by Holt et al., 2008 
 
Isolate Country Year Haplotype 454 
coverage 
Solexa 
coverage 
Plasmid 
E00-7866 Morocco 2000 H46 10.5x - - 
E01-6750 Senegal 2001 H52 8.16x - - 
E02-1180 India 2002 H45 13.1x - - 
E98-0664 Kenya  1998 H55 10.8x - - 
E98-2068 Bangladesh 1998 H42 10.9x - - 
J185SM Indonesia 1985 H85 13.5x - - 
M223 Unknown 1939 H8 11.1x - - 
404ty Indonesia 1983 H59 8.49x 24.6x PBSSB1 
AG3 Vietnam 2004 H58 10.1x 13.1x - 
E98-3139 Mexico 1998 H50 11.1x 5.40x - 
150(98)S Vietnam 1998 H63 - 8.60x - 
8(04)N Vietnam 2004 H58 - 13.1x - 
CT18 Vietnam 1993 H1 - 9.80x PHCM1, 
PHCM2 
E02-2759 India 2002 H58 - 65.5x PHCM2 
E03-4983 Indonesia 2003 H59 - 7.42x PBSSB1 
E03-9804 Nepal 2003 H58 - 8.19x PAKU1 
ISP-03-
07467 
Morocco 2003 H58 - 7.87x PAKU1 
ISP-04-
06979 
Central 
Africa 
2004 H58 - 72.9x PAKU1 
Ty2 Russia 1916 H10 - 8.60x - 
 
 
 
